next-generation sequencing


The whole-exome vs. whole-genome sequencing debate

An enterprising salesperson from Complete Genomics used this newfangled social media thing called LinkedIn to make her mark on the world (perhaps) by posing a discussion question. (It was over at the ‘Genome Interpretation‘ group in case you were wondering.) Entitled, “The last days of exome sequencing“, she posed the […]


Some thoughts on Pacific Biosciences single-molecule sequencing

We’re living through a time this year of market transition. The Illumina HiSeq continues to have a strong market position (although the upcoming Ion Torrent Proton sets out to change that, however it won’t be available until this September / October). For the time being, customers with NGS platforms are […]


What is a new Next Generation Sequencing customer to do?

In the roads I travel (and it is now over six years since I made that fateful move from being an ‘internal’ Product Manager to ‘customer-facing’ sales representative) the buying process is all about perceptions of the customer. Right or wrong, potential customers each receive the information from a local […]


Sequencing equipment provider Pacific Biosciences (PACB) and the rate of change 4

February 2008, Marco Island Florida – an exciting time in the world of NGS, the first pioneering papers were being published using short-read sequencing that are now every-day applications – ChIP, RNA-Seq, small RNA, the first whole genomes.  


Just what is “Next Generation Technologist” about anyway? 1

“The future is already here – it’s just not very evenly distributed.” – William Gibson This is a blog about next-generation sequencing and it’s intersection with marketing and business in general (primarily), which happens to be my particular area of professional expertise, having focused on next-generation sequencing since late 2006, […]